ABION Inc. (KOSDAQ:203400)
South Korea · Delayed Price · Currency is KRW
2,290.00
-150.00 (-6.15%)
At close: Apr 2, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
Biotechnology-Related Research and Development Services | | 1.27B | 2.51B | 1.64B | 1.99B |
Biotechnology-Related Research and Development Services Growth | | -49.16% | 52.98% | -17.82% | - |
| | 1.27B | 2.51B | 1.64B | 1.99B |
| | -49.16% | 52.98% | -17.82% | - |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| | 1.27B | 2.51B | 1.64B | 1.99B |
| | -49.16% | 52.98% | -17.82% | - |
| | 1.27B | 2.51B | 1.64B | 1.99B |
| | -49.16% | 52.98% | -17.82% | - |
Source: S&P Global Market Intelligence.
